Navigation Links
Scientists Decode Brain Cancer Cell Line
Date:1/29/2010

Findings could lead to more effective, less toxic treatments, researchers say

FRIDAY, Jan. 29 (HealthDay News) -- The first complete genomic sequencing of a brain cancer cell line has been performed by U.S. scientists.

The achievement may help identify new molecular targets for the development of more effective and less toxic drugs and lead to personalized treatments based on the unique biological signatures of a patient's cancer, according to the team at the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles.

The finding also may result in new and better ways to monitor for brain cancer recurrence, as well as a test to determine when brain cancer has been destroyed, which would prevent overtreatment with harmful anti-cancer drugs that can cause long-term health problems.

The sequencing was done on a glioblastoma cell line called U87, which is studied in more than 1,000 laboratories worldwide. The UCLA team used this thoroughly examined brain cancer cell line because the sequencing of its genome will allow scientists who've studied it to reinterpret their findings and perhaps move in new research directions.

According to the report published in the Jan. 29 online edition of the journal PLoS Genetics, with the latest technology, the sequencing of the brain cancer cell line took less than a month and cost about $35,000.

"This is very exciting because we, as scientists, can now move forward with revealing complete cancer genomes," study senior author Dr. Stan Nelson, a professor of human genetics and director of the Jonsson Comprehensive Cancer Center's Gene Expression Shared Resource, said in a news release.

"Cancer is at its heart a genetic disease. Cancer cells have acquired mutations that allow them to invade tissues and to not live by the normal rules. The changes from normal (mutations) that have given the cancer these special properties are en
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Scientists show how molecular switch helps pancreatic cancer beat drugs
2. Brain scientists extend map of fear memory formation
3. Scientists Turn Mouse Skin Cells Into Nerve Cells
4. Scientists Find Way to Track Flesh-Eating Bacteria
5. Brain Abnormalities in Parkinson's Patients Develop Before Symptoms Occur, According to Feinstein Scientists
6. Scientists shed new light on walking
7. Scientists discover cells critical to childhood leukemia
8. Scientists show how brain tumors outsmart drugs
9. Weizmann Institute scientists reveal how tendons shape developing bones
10. Scripps Research scientists find cancer cells co-opt fat metabolism pathway to become more malignant
11. Neuroscientists at Case Western Reserve University store information in isolated brain tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 Zereana Jess-Huff, a 34-year-old mother, ... 2014 on a platform to think outside the bra. She ... her position to raise awareness about women’s other lady parts. ... cancer. You say the color pink and everybody knows what ... a fact that it has not been won when it ...
(Date:10/20/2014)... My Clients Plus ( http://www.MyClientsPlus.com ) ... The new module enables easy administration and routing of ... care. , This application allows users such as Therapists ... a to-do item to a specific client, categorize tasks ... reoccurring reminders for follow-ups. It's designed to enable ...
(Date:10/20/2014)... Diego, CA (PRWEB) October 20, 2014 AttorneyOne.com, ... all the latest information from the FDA on Sit ... on October 10 not to purchase or use Sit and ... Sit and Slim II is promoted as weight loss product ... Sibutramine, removed from the market in 2010 for safety reasons, ...
(Date:10/20/2014)... Rockynol Retirement Community broke ... 14. The $11 million project will include the latest ... kitchen with full-service restaurant style dining. , “We are ... class Assisted Living apartments,” said Kara Hanzie, Rockynol Executive ... quality of care and this investment is proof of ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Based ... are the only imaging assays capable of determining ... single test.  With these three dimensions of high-resolution ... to detect the widest range of disease-causing genetic ... missed by other genomic tools, including today’s advanced ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3
... Professor of Psychology, Annenberg Professor of Natural ... Neuroscience, University of Pennsylvania , WHAT: Dr. Farah ... of the symposium Poverty and Brain Development: ... 2008 American Association for the Advancement of ...
... differ on what answers the research offers , , TUESDAY, ... try to answer one of the most pressing questions ... applied to keep open the partially collapsed lungs of ... respiratory distress syndrome? , Unfortunately, that question has not ...
... Phileas Fogg,s 80-Day Around the World Race Updated for ... Oscar Viewing Party February 24, NEW YORK, Feb. ... legends were launched: the Academy Awards and The Leading,Hotels ... milestone, Leading,Hotels has drawn on all the adventure, romance ...
... Northwestern Memorial,HealthCare, corporate parent of Northwestern Memorial ... new members to the Northwestern,Memorial Foundation,s Boards of ... currently serves as president of the Friends of ... Northwestern Memorial Hospital,s,Campaign Steering Committee. Gordon is chairman ...
... Feb. 12 Thomson Healthcare, the,leading provider of ... their efforts to improve clinical and business,performance, announced ... as the Category Leader for Mobile Data Systems ... report released in December 2007., For the ...
... Development Event ... Personal Care Industry, NEW YORK, Feb. 12 Jill ... & Fragrances Business Division,for CMPi, the producers of the HBA ... sales, marketing, and operations of the annual,HBA Global Expo and ...
Cached Medicine News:Health News: Respiratory Distress Treatment Studies Conflict 2Health News: Respiratory Distress Treatment Studies Conflict 3Health News:The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways 2Health News:The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways 3Health News:The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways 4Health News:The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways 5Health News:Northwestern Memorial HealthCare and Northwestern Memorial Foundation Elect New Members to Board of Directors 2Health News:Thomson Healthcare's Clinical Xpert Navigator Tops KLAS Annual Performance Ranking in Mobile Data Systems for Sixth Consecutive Year 2Health News:Thomson Healthcare's Clinical Xpert Navigator Tops KLAS Annual Performance Ranking in Mobile Data Systems for Sixth Consecutive Year 3Health News:Jill Birkett Appointed Event Director for HBA Global Expo 2Health News:Jill Birkett Appointed Event Director for HBA Global Expo 3
(Date:10/19/2014)... , Deutschland, October 19, 2014 ... gefragt. Das Problem dabei ist, dass ... mit der Kompetenz zu teilen. Es ... deshalb freuen wir uns umso mehr, dass es ... ihre Gepflogenheiten bei Kühlketten aufzuschreiben - mit einem ...
(Date:10/17/2014)... , Oct. 17, 2014 With the ... Affairs function has come across several challenges in ... and managing globalization.  The ... is dedicated to providing benchmarking and best practices ... Consortium is a service composed of three stages: ...
(Date:10/17/2014)... Texas , Oct. 17, 2014  Hanger, Inc. ... plans to report its results of operations for the ... 2014 after the market closes.  A conference call to ... a.m., ET, on Friday, November 7, 2014. Those wishing ... available until Friday, November 14, 2014 by dialing 1-855-859-2056 ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Early Key Findings from the Medical Affairs Consortium Research 2
... Calif., Dec. 9, 2010 Ambry Genetics, a global ... sciences industries, announced today that it has officially launched ... Genetics has been an early adapter of Illumina sequencing ... Certified Service Provider. (Logo:   http://photos.prnewswire.com/prnh/20090428/LA06744LOGO ...
... 9, 2010 A new study shows that ... hormonal therapy tamoxifen in patients with hormone-receptor positive/human ... cancer who have been previously treated with an ... tamoxifen alone. These results were presented today at ...
Cached Medicine Technology:Ambry Genetics Launches Illumina HiSeq 2000 Next Generation Sequencing Services 2Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 2Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 3Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 4Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 5Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 6Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 7Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 8Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 9Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 10Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients 11
... An integrated approach to quality patient care., ... an innovative approach to anesthesia delivery. As ... combines enhanced ventilation features, electronically controlled gas ... and information management to create a truly ...
A non-adhering hydrogel sheet dressing for use on all partial and full thickness wounds (excluding 3rd degree burns.) Hydrogel sheet contains 96% water and 4% insoluble cross-linked polyethylene oxid...
... External Vacuum Therapy System restores sexual function ... Non-invasive and low cost vacuum therapy, coupled ... outcome", makes it the ideal therapy for ... System causes penile rigidity that can be ...
... D.O.R.C. Harmony Special Peristaltic phacoemulsification system features ... including individual programmability and remote control for ... a front panel with color coded function ... for ease of use and viewing. Under ...
Medicine Products: